260 related articles for article (PubMed ID: 16197442)
1. Bortezomib-induced Sweet syndrome.
Knoops L; Jacquemain A; Tennstedt D; Theate I; Ferrant A; Van den Neste E
Br J Haematol; 2005 Oct; 131(2):142. PubMed ID: 16197442
[No Abstract] [Full Text] [Related]
2. Sweet-like syndrome induced by bortezomib.
Kolb-Mäurer A; Kneitz H; Goebeler M
J Dtsch Dermatol Ges; 2013 Dec; 11(12):1200-2. PubMed ID: 23905772
[No Abstract] [Full Text] [Related]
3. [Bortezomib-induced acute neutrophilic dermatosis].
Tanguy-Schmidt A; Avenel-Audran M; Croué A; Lissandre S; Dib M; Zidane-Marinnes M; Moles MP; Hunault-Berger M
Ann Dermatol Venereol; 2009 May; 136(5):443-6. PubMed ID: 19442803
[TBL] [Abstract][Full Text] [Related]
4. Bortezomib-induced histiocytoid Sweet syndrome.
Murase JE; Wu JJ; Theate I; Cole GW; Barr RJ; Dyson SW
J Am Acad Dermatol; 2009 Mar; 60(3):496-7. PubMed ID: 19231647
[TBL] [Abstract][Full Text] [Related]
5. Images in clinical Medicine. Bortezomib-induced skin lesions.
Agterof MJ; Biesma DH
N Engl J Med; 2005 Jun; 352(24):2534. PubMed ID: 15958809
[No Abstract] [Full Text] [Related]
6. Bortezomib-induced perivascular dermatitis in a patient with multiple myeloma.
Ozkurt ZN; Sucak GT; Aki SZ; Yağci M; Erdem O
Cutan Ocul Toxicol; 2009; 28(3):141-3. PubMed ID: 19548772
[TBL] [Abstract][Full Text] [Related]
7. Skin lesions induced by bortezomib.
Pour L; Hajek R; Zdenek A; Krejci M; Krivanova A; Vorlicek J
Haematologica; 2005 Dec; 90(12 Suppl):ECR44. PubMed ID: 16464759
[TBL] [Abstract][Full Text] [Related]
8. Sweet-like lesions induced by bortezomib: a review of the literature and a report of 2 cases.
Truchuelo M; Bagazgoitia L; Alcántara J; Velasco D; Carrillo R
Actas Dermosifiliogr; 2012 Nov; 103(9):829-31. PubMed ID: 22652505
[No Abstract] [Full Text] [Related]
9. Distinct variant of Sweet's syndrome: bortezomib-induced histiocytoid Sweet's syndrome in a patient with multiple myeloma.
Kim JS; Roh HS; Lee JW; Lee MW; Yu HJ
Int J Dermatol; 2012 Dec; 51(12):1491-3. PubMed ID: 22998496
[No Abstract] [Full Text] [Related]
10. Bortezomib-induced cutaneous lesions in multiple myeloma patients: a case report.
Rodríguez-Martín M; Sáez-Rodríguez M; García-Bustínduy M; Martín-Herrera A; Noda-Cabrera A
Dermatol Online J; 2008 Nov; 14(11):14. PubMed ID: 19094852
[TBL] [Abstract][Full Text] [Related]
11. Optimizing bortezomib treatment in patients with relapsed multiple myeloma.
Richardson P
Clin Adv Hematol Oncol; 2006 May; 4(5):4-5; discussion 8; suppl 13. PubMed ID: 16832859
[No Abstract] [Full Text] [Related]
12. Bortezomib increases survival of patients with relapsed multiple myeloma.
Health News; 2005 Sep; 11(9):9. PubMed ID: 16211682
[No Abstract] [Full Text] [Related]
13. Bortezomib-induced skin eruption.
Sanchez-Politta S; Favet L; Kerl K; Dietrich PY; Piguet V
Dermatology; 2008; 216(2):156-8. PubMed ID: 18216478
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous lymphoid perivascular reaction with atypical CD30+ T cells in a patient with multiple myeloma treated with bortezomib.
Dehesa L; Bastida J; Limeres-González M; Campos-Adsuar C; Gómez-Duaso J
Clin Exp Dermatol; 2009 Dec; 34(8):e1031-2. PubMed ID: 20055832
[No Abstract] [Full Text] [Related]
15. Severe pulmonary complications after bortezomib treatment for multiple myeloma: an unrecognized pulmonary vasculitis?
Pitini V; Arrigo C; Altavilla G; Naro C
Leuk Res; 2007 Jul; 31(7):1027-8. PubMed ID: 17134751
[No Abstract] [Full Text] [Related]
16. Hyperlipidemia in a myeloma patient after bortezomib treatment.
Gozzetti A; Fabbri A; Defina M; Chitarrelli I; Bocchia M
Leuk Res; 2010 Sep; 34(9):e250. PubMed ID: 20363499
[No Abstract] [Full Text] [Related]
17. Rapid response to high-dose steroids of severe bortezomib-related pulmonary complication in multiple myeloma.
Zappasodi P; Dore R; Castagnola C; Astori C; Varettoni M; Mangiacavalli S; Lazzarino M; Corso A
J Clin Oncol; 2007 Aug; 25(22):3380-1. PubMed ID: 17664489
[No Abstract] [Full Text] [Related]
18. Bortezomib-induced Sweet's syndrome.
Van Regenmortel N; Van de Voorde K; De Raeve H; Rombouts S; Van de Velde A; Lambert J; Schroyens W
Haematologica; 2005 Dec; 90(12 Suppl):ECR43. PubMed ID: 16464758
[TBL] [Abstract][Full Text] [Related]
19. Bortezomib (velcade) for multiple myeloma.
Med Lett Drugs Ther; 2003 Jul; 45(1161):57-8. PubMed ID: 12865865
[No Abstract] [Full Text] [Related]
20. Bortezomib-associated rash: a new recognizable and avoidable side-effect.
Villarrubia B; Betlloch I; Mataix J; Lucas A; Botella C
Br J Dermatol; 2007 Apr; 156(4):784-5. PubMed ID: 17286633
[No Abstract] [Full Text] [Related]
[Next] [New Search]
